Acquired myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction
in which patients experience fluctuating skeletal muscle weakness that often affects selected …

Introduction: Thymoma is a rare tumor for which there is little randomized evidence to guide
treatment. Because of the lack of high-quality evidence, a formal consensus-based …

Objective To investigate the clinical, histological, and immunological features of patients with
myasthenia gravis (MG) who also developed myocarditis and/or myositis. Design …

Thymic malignancy is often associated with paraneoplastic neurological diseases (PNDs)
and recognition of these disorders is important for physicians who treat these patients. The …

Myasthenia gravis is an autoimmune disease caused, in most cases, by antibodies attaching
to the acetylcholine receptor. Some myasthenia gravis patients have antibodies that bind in …

The literature describing multimodal treatment of thymomas consists almost exclusively of
retrospective case series. We have used a systematic review to investigate the role of …

Background Acquired myasthenia gravis (MG) is a rare antibody-mediated autoimmune
disease caused by impaired neuromuscular transmission, leading to abnormal muscle …

Objective Paraneoplastic syndromes associated with thymomas remain incompletely
understood. The objective was to examine the association between surgically resected …

BACKGROUND: The impact of myasthenia gravis on patients with thymoma is still
controversial when perioperative and long-term outcomes are analyzed. With the unique …

Acquired myasthenia gravis (MG) is a chronic autoimmune disorder of the neuromuscular
junction, characterized clinically by muscle weakness and abnormal fatigability on exertion …